Best Pharma Strategies from the Experts

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

At one point in his career, I Don’t Care Host Kevin Stevenson spent some time on the pharma side of things, in between working at hospitals.

Today he dives back into that world with Donovan Quill, President, and CEO at Optime Care, a nationally recognized pharmacy, distribution, and patient management organization that creates the trusted path to a fulfilled life for patients with rare and orphan disorders.

“What we try to do is create a holistic program for those patients where we combine all the services you would see in a pharmacy in a patient care model,” Quill said. “We try to create a one-stop-shop for patients to really get the care they need from a support standpoint, from affordability, and also to distribute their products to them in their home or site of care.”

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand.” – Donovan Quill

Orphan disorders and drugs are a bit different from regular pharmaceuticals. Typically, an orphan drug is a treatment for a condition with less than 200,000 patients in the U.S., according to the FDA definition. But, what they do at Optime Care is treat disorders that are even more rare, or “Ultra orphan,” according to Quill.

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand,” Quill said. “We really try to focus on the patients who need a little extra care.”

Most of the time, the patients they treat have a disorder they’ve never heard of and are treated with a product they can’t pronounce, Quill said jokingly.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Fiber Deployment
Connected America 2025: Smarter Planning and Partnerships Key to Maximizing Fiber’s Federal Funding and Impact
March 31, 2025

As the digital divide accelerates and fiber deployment sees growth, Connected America 2025 has emerged as a pivotal moment for infrastructure professionals. With over $42.5 billion earmarked through federal programs like the Broadband Equity, Access, and Deployment (BEAD) initiative, the U.S. is undergoing one of the most aggressive broadband expansion efforts in its history….

Read More
Workplace safety
Building a Skilled Trades Workforce: Certifications, Simulation-Based Training & Reskilling with SkillCat
March 31, 2025

Industries across the United States are facing an unprecedented shortage of a skilled trades workforce. With millions of baby boomers retiring and fewer young people entering the trades, sectors like HVAC, manufacturing, and construction are grappling with a critical need for talent. This labor shortage is further compounded by a lack of awareness and…

Read More
K-12 school
Tackling All That K-12 Schools Try to Do: The Solutions
March 31, 2025

As public confidence in major institutions continues to erode, the American K–12 education system finds itself straining under the weight of legacy expectations and modern demands. From grading and college recommendations to extracurriculars and character development, K-12 schools are tasked with a near-impossible mission: to do it all, for everyone. At the same time,…

Read More
wellness
The Rise of AI-Powered Wellness: Vitaquest Taps Big Data to Deliver Personalized Nutrition at Scale
March 31, 2025

The wellness industry is at an inflection point. What once centered around pill packs and generic supplement regimens is now being transformed by an ecosystem of personalization, flavor innovation, and data-driven development. According to research, the global nutraceuticals market is on track to surpass $919 billion by 2030—and with consumer demand increasingly favoring tailored,…

Read More